Spago Nanomedical AB (publ) (FRA:7UX)
Germany
· Delayed Price · Currency is EUR 0.0092
+0.0002 (2.22%)
At close: Dec 5, 2025
Spago Nanomedical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 11.26 | 32.47 | 45.22 | 62.1 | 52.46 | 28.45 | Upgrade
|
| Cash & Short-Term Investments | 11.26 | 32.47 | 45.22 | 62.1 | 52.46 | 28.45 | Upgrade
|
| Cash Growth | -71.82% | -28.19% | -27.19% | 18.38% | 84.41% | 134.16% | Upgrade
|
| Accounts Receivable | 0.01 | 0.2 | 0.37 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Other Receivables | - | 4.46 | 3.58 | 0.66 | 0.86 | 0.68 | Upgrade
|
| Receivables | 0.01 | 4.66 | 3.95 | 0.71 | 0.89 | 0.71 | Upgrade
|
| Prepaid Expenses | 4.72 | 1.46 | 2.74 | 2.43 | 1.03 | 0.68 | Upgrade
|
| Other Current Assets | 0.55 | -0 | -0 | - | - | - | Upgrade
|
| Total Current Assets | 16.53 | 38.59 | 51.91 | 65.24 | 54.39 | 29.83 | Upgrade
|
| Property, Plant & Equipment | 0.16 | 0.61 | 0.93 | 0.85 | 1.08 | 1.08 | Upgrade
|
| Long-Term Investments | - | - | - | 0 | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | 8.11 | 7.31 | 6.54 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 131.74 | 128.85 | 125.36 | Upgrade
|
| Other Long-Term Assets | 0.55 | 0.38 | 0.15 | -0 | - | - | Upgrade
|
| Total Assets | 17.24 | 39.58 | 52.99 | 205.95 | 191.62 | 162.82 | Upgrade
|
| Accounts Payable | 2.07 | 2.72 | 6.39 | 4.73 | 3.86 | 0.93 | Upgrade
|
| Accrued Expenses | 1.85 | 1.82 | 1.53 | 1.56 | 1.49 | 1.44 | Upgrade
|
| Other Current Liabilities | 0.27 | 1.32 | 3.56 | 2.51 | 1.47 | 0.78 | Upgrade
|
| Total Current Liabilities | 4.19 | 5.86 | 11.48 | 8.8 | 6.81 | 3.15 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.56 | 0.38 | 0.15 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.14 | 0.1 | 0.04 | - | - | -0 | Upgrade
|
| Total Liabilities | 4.89 | 6.35 | 11.67 | 8.8 | 6.81 | 3.15 | Upgrade
|
| Common Stock | 12.35 | 3.48 | 18.86 | 90.94 | 41.18 | 31.55 | Upgrade
|
| Additional Paid-In Capital | - | 282.1 | 270.56 | 257.15 | 255.37 | 200.8 | Upgrade
|
| Retained Earnings | - | - | - | -150.93 | -111.74 | -72.67 | Upgrade
|
| Comprehensive Income & Other | - | -252.35 | -248.1 | - | - | 0 | Upgrade
|
| Total Common Equity | 12.35 | 33.24 | 41.32 | 197.16 | 184.81 | 159.68 | Upgrade
|
| Shareholders' Equity | 12.35 | 33.24 | 41.32 | 197.16 | 184.81 | 159.68 | Upgrade
|
| Total Liabilities & Equity | 17.24 | 39.58 | 52.99 | 205.95 | 191.62 | 162.82 | Upgrade
|
| Net Cash (Debt) | 11.26 | 32.47 | 45.22 | 62.1 | 52.46 | 28.45 | Upgrade
|
| Net Cash Growth | -71.82% | -28.19% | -27.19% | 18.38% | 84.41% | 134.16% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.11 | 0.46 | 0.97 | 1.33 | 1.05 | Upgrade
|
| Filing Date Shares Outstanding | 348.2 | 348.2 | 219.51 | 90.94 | 41.18 | 31.54 | Upgrade
|
| Total Common Shares Outstanding | 348.2 | 348.2 | 219.51 | 90.94 | 41.18 | 31.54 | Upgrade
|
| Working Capital | 12.34 | 32.72 | 40.43 | 56.45 | 47.58 | 26.69 | Upgrade
|
| Book Value Per Share | 0.04 | 0.10 | 0.19 | 2.17 | 4.49 | 5.06 | Upgrade
|
| Tangible Book Value | 12.35 | 33.24 | 41.32 | 189.04 | 177.5 | 153.13 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.10 | 0.19 | 2.08 | 4.31 | 4.85 | Upgrade
|
| Machinery | - | 4.27 | 4.8 | 4.45 | 4.31 | 3.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.